Investment In a Quebec Public-Private Partnership to Support the Use of Personalized Medicine Solutions in the Treatment of Cancer Patients
The Government of Qu茅bec announced today a $10 million investment in the Personalized Medicine Partnership for Cancer (PMPC). This public-private partnership will be focused on establishing an integrated approach for the development and implementation of clinical biomarkers and other personalized healthcare solutions to improve the outcome and cost-efficiency of healthcare services provided to cancer patients in the province of Qu茅bec and abroad.
Study shows majority of smokers re-ignite their habit following heart attack
Despite obvious motivation for quitting, 2/3 of patients will resume smoking within twelve monthsAddiction: abnormal communication in the brain
Addiction to cigarettes, drugs and other stimulants has been linked in the past to the brain鈥檚 frontal lobes, but now there is scientific evidence that indicates where in the frontal cortex addiction takes hold and how.聽 Addiction could be a result of abnormal communication between two areas of the frontal lobes linked to decision-making.聽 The discovery will undoubtedly stimulate clinical work on new therapies for millions of people who suffer from addiction.
When it Comes to Pharmaceutical Research, Canada is Missing Out
John Bergeron
海角社区 board demands funds be restored
海角社区鈥檚 board of governors has adopted a resolution demanding the Quebec government withdraw the cuts it is imposing on universities and restore the funding that was in place, saying the government鈥檚 action is 鈥渆xcessive and injurious鈥� to the university.
National network evaluating drug safety reports early results
Prescription medications remain one of the most common causes of severe adverse reactions in clinical medicine, accounting for thousands of deaths annually in Canada.
Fixing the other Health Care Issue; Unique Challenges
"Despite high per-capita spending, health care in Canada consistently underperforms, according to the Commonwealth Fund, which tracks indicators for accessibility, timeliness and outcomes across a number of developed countries. The system that is straining to meet demand today will face an even higher burden in the years ahead, as the population ages.